Linking Hypothermia and Altered Metabolism with TrkB Activation

Article Properties

• Language

  English
• DOI (url)

  10.1021/acschemneuro.3c00350
• Publication Date

  2023/08/08
• Journal

  ACS Chemical Neuroscience
• Indian UGC (journal)
• Refrences

  97
• Citations

  1
• Okko Alitalo Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, FinlandSleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland
• Gemma González-Hernández Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, FinlandSleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland
• Marko Rosenholm Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, FinlandSleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, FinlandCenter for Translational Neuromedicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark
• Piia Kohtala Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, FinlandSleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, FinlandDepartment of Psychiatry, Weill Cornell Medicine, New York, New York 10021, United States
• Nobuaki Matsui Faculty of Pharmacy, Gifu University of Medical Science, 4-3-3 Nijigaoka, Kani, Gifu 509-0293, Japan
• Heidi Kaastrup Müller Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus N 8200, Denmark
• Wiebke Theilmann Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland
• Anders Klein Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen DK-2200, DenmarkDepartment of Drug Design & Pharmacology, University of Copenhagen, Copenhagen DK-2100, Denmark
• Olli Kärkkäinen School of Pharmacy, University of Eastern Finland, Kuopio 70210, FinlandAfekta Technologies Ltd., Kuopio 70210, Finland
• Stanislav Rozov Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, FinlandSleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland
• Tomi Rantamäki Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, FinlandSleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland
• Samuel Kohtala Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, FinlandSleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, FinlandDepartment of Psychiatry, Weill Cornell Medicine, New York, New York 10021, United States ORCID